Health
Ceftazidime flagged as a potential inhibitor of the SARS-COV-2 virus – News-Medical.Net
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndr…
After screening more than 3,500 FDA-approved drugs and small molecules, researchers at the Chinese Academy of Sciences found that ceftazidime, an antibiotic approved for use in treating pneumonia, binds to the receptors that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to in human cells. This drug could potentially be used to prevent virus infection. The research is published on the bioRxiv* preprint server in September 2020.
To combat the spread of COVID-19, researche…
-
Business23 hours agoWhy this investing expert is calling time on NAB shares
-
General20 hours agoFederal government funding extends cohealth GP services until July 2026
-
Noosa News18 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
Business22 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend